Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 antidiabetic agent trial in Japan (jRCT2080225148)
jRCT2080225148Phase 1Completed
- Start
- Mar 2020
- Countries
- 1
01
Overview
Phase 1 trial in type 2 diabetes mellitus (T2DM). Started Mar 2020; status: completed.
02
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT2080225148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080225148.